Lab
Omni Women's Health Medical Group, INC
Omni Women's Health Medical Group, INC was paid $1.66M by Medicaid between Jan 2018 and Nov 2024, across 14 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 20% of everything it billed.
33Billing provider infoOMNI WOMEN'S HEALTH MEDICAL GROUP, INC
FRESNO, CA 93726
FRESNO, CA 93726
33aNPI1891997813assigned 06/01/2007
33bProvider typeClinical Medical Laboratory
28Total paid$1.66M
24GClaims274,203
24DCodes billed14
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#156 of 561
Median peer was paid$222K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,013 | $454K | |
| 2019 | 55,734 | $192K | |
| 2020 | 43,244 | $174K | |
| 2021 | 39,398 | $297K | |
| 2022 | 34,069 | $205K | |
| 2023 | 28,210 | $209K | |
| 2024incomplete | 14,535 | $126K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 20% | 52,555 | 51,255 | $329K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 20% | 52,530 | 51,232 | $327K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 17% | 47,478 | 46,256 | $283K |
| 81513 | 14% | 17,307 | 17,250 | $227K | |
| 87481 | 12% | 42,906 | 42,163 | $193K | |
| 87511 | 6.3% | 25,220 | 24,559 | $105K | |
| 87799 | 4.6% | 5,531 | 5,503 | $76K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2.8% | 6,743 | 6,739 | $46K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.4% | 3,329 | 3,081 | $40K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.4% | 19,425 | 19,080 | $23K |
| 87510 | <1% | 375 | 374 | $4K | |
| 87480 | <1% | 375 | 374 | $4K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGROOMS, HAROLD (DIRECTOR)